[1
]
From the Division of Inflammation Resesarch, Center for Molecular Medicine, Jichi
Medical University, Tochigi, Japan (F.U., K.S., H.K., K.T., A.K., T.K., M.T.); Department
of Molecular Oncology, Shinshu University Graduate School of Medicine, Matsumoto,
Japan (J.S., S.T.); Department of Surgery and Clinical Science, Yamaguchi University
Graduate School of Medicine, Ube, Japan (K.Y.); Cardiovascular Research Institute,
Kurume University, Kurume, Japan (H.A.); Department of Microbiology, Hyogo College
of Medicine, Nishinomiya, Japan (H.T.); and Department of Cell Biology, Japanese Foundation
for Cancer Research, Cancer Institute, Tokyo, Japan (T.N.).
[2
]
From the Division of Inflammation Resesarch, Center for Molecular Medicine, Jichi
Medical University, Tochigi, Japan (F.U., K.S., H.K., K.T., A.K., T.K., M.T.); Department
of Molecular Oncology, Shinshu University Graduate School of Medicine, Matsumoto,
Japan (J.S., S.T.); Department of Surgery and Clinical Science, Yamaguchi University
Graduate School of Medicine, Ube, Japan (K.Y.); Cardiovascular Research Institute,
Kurume University, Kurume, Japan (H.A.); Department of Microbiology, Hyogo College
of Medicine, Nishinomiya, Japan (H.T.); and Department of Cell Biology, Japanese Foundation
for Cancer Research, Cancer Institute, Tokyo, Japan (T.N.). masafumi2@jichi.ac.jp.